Yue-Sheng (Luke) Li

Title: Innovations of Yue-Sheng (Luke) Li

Introduction

Yue-Sheng (Luke) Li is an accomplished inventor based in Thousand Oaks, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing diseases mediated by interferon-gamma, a crucial cytokine in the immune response.

Latest Patents

Yue-Sheng (Luke) Li holds a patent for "Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors." This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-γ) and methods for treating IFN-γ mediated diseases by administering a pharmaceutically effective amount of antibodies to IFN-γ. Additionally, methods of detecting the amount of IFN-γ in a sample using antibodies to IFN-γ are also included in this patent. He has 1 patent to his name.

Career Highlights

Throughout his career, Yue-Sheng (Luke) Li has worked with notable companies in the biotechnology sector, including Medarex Inc. and Amgen Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Yue-Sheng (Luke) Li has collaborated with esteemed colleagues such as Andrew A Welcher and Hilary T Chute. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Yue-Sheng (Luke) Li is a prominent inventor whose work in developing therapeutic antibodies has the potential to significantly impact the treatment of IFN-γ mediated diseases. His contributions to biotechnology continue to pave the way for future innovations in the field.